<DOC>
	<DOCNO>NCT00170885</DOCNO>
	<brief_summary>The purpose study de novo renal transplant patient evaluate effect renal function optimize new regimen comparison standard everolimus exposure plus low-dose cyclosporine microemulsion regimen .</brief_summary>
	<brief_title>Everolimus Combination With Cyclosporine Microemulsion de Novo Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Recipients decease , live unrelated , nonhuman leukocyte antigen ( HLA ) identical living relate donor renal transplant actually viable kidney transplant time randomization ( within 24 hour graft reperfusion ) The renal cold ischemic time must &lt; 36 hour . The age donor must 15 65 year . Patients recipients multiple organ transplant , include one kidney Patients previously receive organ transplant fail within one year Patients current panel reactive Tcell antibody titer 50 % Patients recipients ABO incompatible transplant Tcell crossmatch positive transplant Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>acute rejection</keyword>
	<keyword>renal function</keyword>
	<keyword>everolimus</keyword>
	<keyword>cyclosporine microemulsion</keyword>
</DOC>